Abstract:BACKGROUND Cerebrotendinous xanthomatosis (CTX) is a treatable autosomal recessive inherited metabolic disorder. It results from a deficiency of sterol 27-hydroxylase (CYP27A1), which is a mitochondrial cytochrome P450 enzyme that catalyzes the hydroxylation of cholesterol and modulates cholesterol homeostasis. Patients with CYP27A1 deficiency show symptoms related to excessive accumulation of cholesterol and cholestanol in lipophilic tissues such as the brain, eyes, tendons, and vessels, resulting in juvenile cataracts, tendon xanthoma, chronic diarrhea, cognitive impairment, ataxia, spastic paraplegia, and peripheral neuropathy. CTX is underdiagnosed as knowledge of the disorder is mainly based on case reports. CASE SUMMARY A Chinese family with CTX consisting of one patient and four heterozygous carriers was studied. The patient is a 47-year-old male, who mainly had psychiatric signs but without some cardinal features of CTX such as cataracts, cerebellar ataxia, pyramidal signs and chronic diarrhea. There was a significant increase in the concentration of free fatty acid compared to normal range. Doppler ultrasound of the urinary system showed multiple left kidney stones, a right kidney cyst, and a hypoechoic area in the bladder, which could move with body position. Sagittal and axial magnetic resonance imaging (MRI) of the right ankle joint showed apparent enlargement of the right Achilles tendon and upper medial malleolus flexor tendon, abnormal thickening of the plantar fat, and a small amount of exudation around the fascia in front of the Achilles tendon. Cerebral MRI suggested white matter (WM) demyelination and slight cerebral atrophy. The diagnosis was confirmed by targeted sequencing, which identified compound heterozygous mutations in exon 2 and intron 7 of the CYP27A1 gene (c.435G>T, c.1263+1G>A). Treatment for 3 wk with a combination of lipid-lowering and antipsychotic therapy improved his psychiatric symptoms and normalized the levels of serum free fatty acid. Sediments in the bladder disappeared after therapy. CONCLUSION CYP27A1 genetic analysis should be the definitive method for CTX diagnosis. This case suggests that urinary system diseases may be neglected in CTX patients. The clinical, biological, radiological, and genetic characteristics of CTX are summarized to promote early diagnosis and treatment of this disease.

Advance of clinical and genetic studies on Cockayne syndrome

Dysregulation of gene expression as a cause of Cockayne syndrome neurological disease

Atypical Features in Two Adult Patients with Cockayne Syndrome and Analysis of Genotype–phenotype Correlation

Clinical characteristics, treatment and follow-up of Cockayne syndrome with renal involvement

Ocular Findings in a Patient with Cockayne Syndrome with Two Mutations in the ERCC6 Gene.

Two Novel Heterozygous Mutations in Ercc8 Cause Cockayne Syndrome in A Chinese Patient

Novel Frame Shift Mutation in ERCC6 Leads to a Severe Form of Cockayne Syndrome with Postnatal Growth Failure and Early Death: A Case Report and Brief Literature Review

Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A

A compound heterozygous mutation of ERCC8 is responsible for a family with Cockayne syndrome

Two Novel Mutations in Ercc6 Cause Cockayne Syndrome B in A Chinese Family

A matter of delicate balance: Loss and gain of Cockayne syndrome proteins in premature aging and cancer

A Complex Intragenic Rearrangement of ERCC8 in Chinese Siblings with Cockayne Syndrome

Clinical Characteristics and Prognosis Analysis of 157 Cases with Crow-Fukase Syndrome

Cockayne Syndrome-Associated CSA and CSB Mutations Impair Ribosome Biogenesis, Ribosomal Protein Stability, and Global Protein Folding

Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.

Xeroderma pigmentosum--Cockayne syndrome complex: a further case

Maternal Origin of a De Novo Microdeletion Spanning the ERCC6 Gene in a Classic Form of the Cockayne Syndrome.

Identifying of the ERCC8 gene mutations in a pedigree with Cockayne syndrome

Rescue of Premature Aging Defects in Cockayne Syndrome Stem Cells by CRISPR/Cas9-mediated Gene Correction

Cockayne Syndrome Patient iPSC-Derived Brain Organoids and Neurospheres Show Early Transcriptional Dysregulation of Biological Processes Associated with Brain Development and Metabolism

A Cockayne-like phenotype resulting from a de novo variant in MORC2: expanding the phenotype of MORC2-related disorders